Date Filed | Type | Description |
08/02/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
05/11/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
02/09/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
11/14/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
11/10/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
08/10/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
05/09/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
02/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
11/12/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
08/03/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/06/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/08/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/03/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/12/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/25/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
07/20/2018 |
4
| JOHNSON & JOHNSON (10% Owner) has filed a Form 4 on Provention Bio, Inc.
Txns:
| Converted 2,400,000 shares
@ $0 Converted 2,400,000 preferred shares
@ $0 |
|
07/03/2018 |
3
| JOHNSON & JOHNSON (10% Owner) has filed a Form 3 on Provention Bio, Inc. |
05/07/2018 |
4
| JOHNSON & JOHNSON (10% Owner) has filed a Form 4 on Inspire Medical Systems, Inc.
Txns:
| Converted 197,863 shares
@ $0 Converted 37,388 shares
@ $0 Converted 1,145,038 preferred shares
@ $0 Converted 248,631 preferred shares
@ $0 |
|
05/02/2018 |
3
| JOHNSON & JOHNSON (10% Owner) has filed a Form 3 on Inspire Medical Systems, Inc. |
11/22/2017 |
4
| JOHNSON & JOHNSON (10% Owner) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns:
| Sold 18,367,346 shares
@ $2.75, valued at
$50.5M
|
|
09/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/18/2016 |
4
| JOHNSON & JOHNSON (10% Owner) has filed a Form 4 on Protagonist Therapeutics, Inc |
08/10/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
02/12/2016 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
02/12/2016 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
01/24/2012 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
01/24/2012 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
02/10/2011 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
04/14/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |